Aileen Wang

Chief Financial Officer at Clover Biopharmaceuticals

Aileen Wang serves as Chief Financial Officer at Clover. Aileen Wang is an experienced finance executive with 25 years of experience in the U.S. and Greater China. She has a wealth of experience building business planning and resource allocation processes to accelerate business productivity. She has served as Clover’s Vice President of Finance since March 2021. Prior to Clover, Ms. Wang worked for Novartis for 10 years and held several senior leadership positions, including Head of Core Business Planning & Analysis for Novartis Gene Therapies at its U.S. headquarters and Chief Financial Officer for Sandoz China. During her tenure with Novartis, she led and overhauled multiple finance teams including building the finance function for a newly established business unit while successfully transforming its resource planning process to double the productivity and achieve accelerated growth. Earlier in her career, she held managerial roles with Motorola Inc. and Arthur Andersen LLP.

Ms. Wang earned her MBA from Pennsylvania State University and a bachelor’s degree in engineering from Shanghai Jiao Tong University. She was also an Illinois-registered certified public accountant.

Timeline

  • Chief Financial Officer

    Current role

View in org chart